학술논문
The potential impact of pharmacogenetic testing on medication adherence
Document Type
Report
Author
Source
The Pharmacogenomics Journal. December 1, 2013, Vol. 13 Issue 6, p481, 3 p.
Subject
Language
English
ISSN
1470-269X
Abstract
Pharmacogenetic (PGx) testing provides information about a patient's likelihood to have an adverse response and/or a therapeutic response to a medication, enabling the potential for a tailored and personalized approach [...]
Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients' confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication- taking behavior. The Pharmacogenomics Journal (2013) 13, 481-483; doi: 10.1038/tpj.2013.33; published online 3 September 2013 Keywords: clinical care; medication adherence; outcomes; patient attitudes; pharmacogenetics
Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients' confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication- taking behavior. The Pharmacogenomics Journal (2013) 13, 481-483; doi: 10.1038/tpj.2013.33; published online 3 September 2013 Keywords: clinical care; medication adherence; outcomes; patient attitudes; pharmacogenetics